Posts Under: Products

Launching of three new CE-IVD kit, based on Real Time PCR technology, to determine the risk to suffer thrombosis

We are very proud of announcing the launching of three new CE-IVD kit, based on Real Time PCR technology, to determine the risk to suffer thrombosis.
Venous thrombosis is one of the most frequent cardiovascular diseases. It is happened by blood coagulation in the inner of the veins. The risk to suffer this disease can be determined genetically. Several mutations have been described, related to this risk increasing, among them G20210A (protrombin), C677T (MTHFR) and G1619A (Factor V). All of them are detected with our new Genvinset® kits:

• Genvinset® Factor II G20210A
• Genvinset® Factor V G1691A
• Genvinset® MTHFR C677T

If you need any further information on this regard, please contact us (info@bdrdiagnostics.com).

BDR announces its new product for in vitro diagnosis of Friedreich´s Ataxia

Blackhills Diagnostic Resources offers its new product Adellgene® Friedreich´s Ataxia, expanding its catalog for fragment analysis products.

Friedreich’s ataxia is the most common hereditary ataxia. It is an autosomal recessive degenerative disease characterized by a progressive gait and limb ataxia, a lack of tendon reflexes in the legs, loss of position sense, dysarthria, and pyramidal weakness of the legs.

The cause of this disease is an abnormality of the DNA consisting of a repeat expansion GAA triplet in the gene encoding Frataxin. Thus, people who are between 5-30 repeats are healthy individuals, those between 30-49 repeats are patients with mild symptoms and those between 50 to 1,300 repeats are patients with severe symptoms.

The Adellgene® Friedreich Ataxia product is an in vitro diagnostic kit that detects the number of repeats of GAA triplet. The technology is based on amplification of genomic DNA from peripheral blood samples using polymerase chain reaction (PCR), followed by a fluorescent size analysis of PCR fragments obtained by genetic analyzer and converting said size in the number of repetitions of GAA.

Adellgene®: rare diseases diagnosis

Blackhills Diagnostic Resources offers our product line Adellgene®, based on the fragment analysis for molecular diagnosis of diseases of triplets: Fragile X syndrome, Huntington’s chorea, myotonic dystrophy, Friedreich’s Ataxia, etc. The technology used is based on DNA amplification by PCR, followed by a fluorescent analysis of the fragments obtained.
More information

HLA alleles associated to disease: Genvinset® products.

The HLA system is a group of genes, most highly polymorphic, whose products are expressed in a wide variety of cells and are responsible for the adaptive immune response.
The presence of certain HLA alleles is associated with the predisposition to some diseases. Blackhills Diagnostic Resources is specialized in product development for the study of these diseases by PCR technology Real Time.
More information